New United States guidelines recommending human papilloma virus screening for women with borderline cervical cytological abnormalities

Following two conferences which took place in the United States (US) last year, the American Medical Association has recently published two consensus statements concerning screening for and management of cervical cancer (1-3). It is recommended that human papilloma virus (HPV) testing become an integral part of both screening and clinical management of cervical cytological abnormalities.